SureNano Announces Closing of $1,250,000 Private Placement

Executive Summary

• SureNano Science Ltd. closed a non‑brokered private placement raising $1,250,000 through the issuance of 10,000,000 units at $0.125 per unit.
• Each unit consists of one common share and one warrant to purchase an additional share at $0.35 for 24 months; finders received cash commissions and additional warrants as compensation.
• Proceeds are earmarked for operating expenses, legal/audit fees, working‑capital needs, market expansion of the SureNano™ surfactant, and potential business combination transactions.

Key Details

• Units Issued: 10,000,000 units @ $0.125 each → $1,250,000 gross proceeds.
• Unit Composition: 1 common share + 1 common‑share purchase warrant (exercise price $0.35, 24‑month term).
• Acceleration Provision: If CSE share price ≥ $0.50 for ten consecutive trading days after four months + one day post‑closing, the company may accelerate warrant expiry to 30 days after notice.
• Finder Compensation:
• Cash commission of $75,000 paid to finders.
• Additional 600,000 finder’s warrants issued (each for one common share at $0.35, 24‑month term, subject to acceleration).
• Finder compensation rate: 6% cash + 6% warrants on amounts introduced.
• Holding Period: All securities subject to a hold period expiring four months + one day from issuance under Canadian securities law.
• Use of Proceeds:
• Operating expenses (legal, audit, general working capital).
• Exploration of new markets for the SureNano™ surfactant.
• Evaluation and potential execution of business combinations or acquisitions, pending board approval.

Notable Quotes

“The Company intends to use proceeds of the Private Placement for operating expenses, including legal and audit fees, general working capital, expenses related to exploring new markets for its SureNano™ surfactant, and continuing to evaluate potential business combinations with complementary companies.” – Charles MaLette, CEO, President, Director & Secretary.